Demonstration of PDC-E1 subunits as major antigens in the complement-fixing fraction M4 and re-evaluation of PDC-E1-specific antibodies in PBC patients

Liver International

Volumn 26, Issue 7, 2006, Pages 846-855

  Berg, Christoph P ^a   Stein, Gerburg M ^a   Klein, Reinhild ^a   Pascu, Maria ^b   Berg, Thomas ^b   Kammer, Winfried ^c   Priemer, Martin ^c   Nordheim, Alfred ^c   Schulze osthoff, Klaus ^d   Gregor, Michael ^a   Wesselborg, Sebastian ^a,c   Berg, Peter A ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c UNIVERSITY OF TÜBINGEN   (Germany)

^d HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Affinity chromatography; Fragments of oxoacid dehydrogenase complex; Mitochondrial antigens; Primary biliary cirrhosis; Pyruvate dehydrogenase complex E1 chain

Indexed keywords

ENZYME ANTIBODY; IMMUNOGLOBULIN G; PYRUVATE DEHYDROGENASE COMPLEX;

ADULT; AFFINITY CHROMATOGRAPHY; AGED; AMINO ACID SEQUENCE; ANTIBODY SPECIFICITY; ANTIGEN DETECTION; ARTICLE; BLOOD ANALYSIS; COMPLEMENT FIXATION TEST; CONTROLLED STUDY; ENZYME MECHANISM; ENZYME SUBUNIT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIMARY BILIARY CIRRHOSIS; PROTEIN PURIFICATION; SEQUENCE ANALYSIS; SILVER STAINING; WESTERN BLOTTING;

AGED; AGED, 80 AND OVER; ANIMALS; AUTOANTIBODIES; AUTOANTIGENS; COHORT STUDIES; COMPLEMENT FIXATION TESTS; FEMALE; HUMANS; IMMUNODOMINANT EPITOPES; LIVER CIRRHOSIS, BILIARY; MALE; MIDDLE AGED; MITOCHONDRIA; PYRUVATE DEHYDROGENASE (LIPOAMIDE); PYRUVATE DEHYDROGENASE COMPLEX; RATS;

EID: 33746768708     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2006.01303.x     Document Type: Article

References (36)

1. Sherlock S, Scheuer P J. The presentation and diagnosis of 100 patients with primary biliary cirrhosis. N Engl J Med 1973; 289: 674-8.
2. Gershwin E M. Molecular analysis of cytoplasmic autoantigens in liver disease. In: Rose NR, Mackay IR, eds. Molecular Analysis of Cytoplasmic Autoantigens in Liver Disease. San Diego: Academic Press, 1992; 213-33.
3. Fussey S P, Bassendine M F, Fittes D, et al. The E1 alpha and beta subunits of the pyruvate dehydrogenase complex are M2'd'and M2'e'autoantigens in primary biliary cirrhosis. Clin Sci (London) 1989; 77: 365-8.
4. Fregeau D R, Roche T E, Davies P A, et al. Primary biliary cirrhosis. Inhibition of pyruvate dehydrogenase complex activity by autoantibodies specific for E1 alpha, a non-lipoic acid containing mitochondrial enzyme. J Immunol 1990; 144: 1671-6.
5. Berg P A, Klein R. Mitochondrial antigen/antibody systems in primary biliary cirrhosis: Revisited. Liver 1995; 15: 281-92.
6. Yeaman S J, Fussey S P, Mutimer D J, et al. M2 autoantigens in primary biliary cirrhosis. Lancet 1989; 1: 103.
7. Miyakawa H, Tanaka A, Kikuchi K, et al. Detection of antimitochondrial autoantibodies in immunofluorescent AMA-negative patients with primary biliary cirrhosis using recombinant autoantigens. Hepatology 2001; 34: 243-8.
8. Fregeau D R, Davis P A, Danner D J, et al. Antimitochondrial antibodies of primary biliary cirrhosis recognize dihydrolipoamide acyltransferase and inhibit enzyme function of the branched chain alpha-ketoacid dehydrogenase complex. J Immunol 1989; 142: 3815-20.
9. Van De Water J, Fregeau D, Davis P A, et al. Autoantibodies of primary biliary cirrhosis recognize dihydrolipoamide acetyltransferase and inhibit enzyme function. J Immunol 1988; 141: 2321-4.
10. Yeaman S J, Kirby J A, Jones D E. Autoreactive responses to pyruvate dehydrogenase complex in the pathogenesis of primary biliary cirrhosis. Immunol Rev 2000; 174: 238-49.
11. Weber P, Brenner J, Stechemesser E, et al. Characterization and clinical relevance of a new complement-fixing antibody -anti-M8 -in patients with primary biliary cirrhosis. Hepatology 1986; 6: 553-9.
12. Klein R, Berg P A. Anti-M4 antibodies in primary biliary cirrhosis react with sulphite oxidase, an enzyme of the mitochondrial inter-membrane space. Clin Exp Immunol 1991; 84: 445-8.
13. Palmer J M, Yeaman S J, Bassendine M F, James O F. M4 and M9 autoantigens in primary biliary cirrhosis-a negative study. J Hepatol 1993; 18: 251-4.
14. Engels I H, Stepczynska A, Stroh C, et al. Caspase-8/FLICE functions as an executioner caspase in anticancer drug-induced apoptosis. Oncogene 2000; 19: 4563-73.
15. Blum H, Beier H, Gross H J. Improved silver staining of plant proteins, RNA and DNA in polyacrylamid gels. Electrophoresis 1987; 8: 93-99.
16. Blakesley R W, Boezi J A. A new staining technique for proteins in polyacrylamide gels using Coomassie brilliant blue G250. Anal Biochem 1977; 82: 580-2.
17. Shevchenko A, Chernushevich I, Ens W, et al. Rapid 'de novo'peptide sequencing by a combination of nanoelectrospray, isotopic labelling and a quadrupole/time-of-flight mass spectrometer. Rapid Commun Mass Spectrom 1997; 11: 1015-24.
18. Lautwein A, Kraus M, Reich M, et al. Human B lymphoblastoid cells contain distinct patterns of cathepsin activity in endocytic compartments and regulate MHC class II transport in a cathepsin S-independent manner. J Leukoc Biol 2004; 75: 844-55.
19. Palmer J M, Kirby J A, Jones D E. The immunology of primary biliary cirrhosis: The end of the beginning? Clin Exp Immunol 2002; 129: 191-7.
20. Mori T, Ono K, Hakozaki M, Kochi H. Epitope mapping on E1alpha subunit of pyruvate dehydrogenase complex with autoantibodies of patients with primary biliary cirrhosis. Liver Int 2003; 23: 355-62.
21. Selmi C, Gershwin M E. Bacteria and human autoimmunity: The case of primary biliary cirrhosis. Curr Opin Rheumatol 2004; 16: 406-10.
22. Xu L, Shen Z, Guo L, et al. Does a betaretrovirus infection trigger primary biliary cirrhosis. Proc Natl Acad Sci USA 2003; 100: 8454-9.
23. Gershwin M E, Ansari A A, Mackay I R, et al. Primary biliary cirrhosis: an orchestrated immune response against epithelial cells. Immunol Rev 2000; 174: 210-25.
24. Huh T L, Casazza J P, Huh J W, et al. Characterization of two cDNA clones for pyruvate dehydrogenase E1 beta subunit and its regulation in tricarboxylic acid cycle-deficient fibroblast. J Biol Chem 1990; 265: 13320-6.
25. Sayers T J, Binder T, Berg P A. Heterogeneity of anti-mitochondrial antibodies: Characterization and separation of the antigen associated with the pseudolupus erythematosus syndrome. Clin Exp Immunol 1979; 37: 68-75.
26. Berg P A, Wiedmann K H, Sayers T, et al. Serological classification of chronic cholestatic liver disease by the use of two different types of antimitochondrial antibodies. Lancet 1980; 2: 1329-32.
27. Klöppel G, Kirchhof M, Berg P A. Natural course of primary biliary cirrhosis. I. A morphological, clinical and serological analysis of 103 cases. Liver 1982; 2: 141-51.
28. Jones D E, Bhala N, Newton J L. Reflections on therapeutic trials in primary biliary cirrhosis: A quality of life oriented counter-view. Hepatology 2006; 43: 633; author reply 634.
29. Combes B, Emerson S S. Reply. Hepatology 2006; 43: 632-3.
30. Chauhan S S, Zucker S D. Hypercholesterolemia in primary biliary cirrhosis: Getting to the heart of the matter? Gastroenterology 2003; 124: 854-6.
31. Kaplan M M. Primary biliary cirrhosis: Past, present, and future? Gastroenterology 2002; 123: 1392-4.
32. Prince M, Chetwynd A, Newman W, et al. Survival and symptom progression in a geographically based cohort of patients with primary biliary cirrhosis: Follow-up for up to 28 years. Gastroenterology 2002; 123: 1044-51.
33. Kaplan M M, Gershwin M E. Primary biliary cirrhosis. N Engl J Med 2005; 353: 1261-73.
34. Giorgini A, Selmi C, Invernizzi P, et al. Primary biliary cirrhosis: solving the enigma. Ann NY Acad Sci 2005; 1051: 185-93.
35. Beechey R B, Hubbard S A, Linnett P E, et al. A simple and rapid method for the preparation of adenosine triphosphatase from submitochondrial particles. Biochem J 1975; 148: 533-7.
36. Lindenborn-Fotinos J, Sayers T J, Berg P A. Mitochondrial antibodies in primary biliary cirrhosis. VI. Association of the complement fixing antigen with a component of the mitochondrial F1-ATPase complex. Clin Exp Immunol 1982; 50: 267-74.